West-Ward Columbus Inc. is recalling 2,673 cartons of Methotrexate Tablets (2.5 mg) because some tablets were found to have an unsmooth surface or illegible identification markings and scoring. Methotrexate is a prescription medication used to treat certain types of cancer and severe skin or joint conditions. This voluntary recall affects three specific lots distributed in Mississippi and Ohio.
Illegible identification markings on medication can lead to confusion about the drug's identity, while illegible scoring may cause patients to split the tablets incorrectly, potentially leading to inaccurate dosing.
You have 2 options:
Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. Recall #: D-0066-2024
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.